Hepatobiliary Surgery and Nutrition

Article	Citations
2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights	250
Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma	90
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)	54
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease	53
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional O	45
Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma	43
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?	40
International expert consensus on laparoscopic pancreaticoduodenectomy*	40
Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes	37
Neuroendocrine liver metastases: a contemporary review of treatment strategies	34
Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians	29
Optimization of the future remnant liver: review of the current strategies in Europe	25
Biliary complications after liver transplantation: current perspectives and future strategies	25
A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis	25
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model	24
Downstaging and resection of hepatocellular carcinoma in patients with extrahepatic metastases after stereotactic therapy	23
Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection	23
Gd-EOB-DTPA-enhanced MRI radiomic features for predicting histological grade of hepatocellular carcinoma	21
Diagnosis-related Groups (DRG) pricing and payment policy in China: where are we?	20
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease	20
Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients	19
When a new definition overhauls perceptions of MAFLD related cirrhosis care	19
Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients	19
Preparing for liver surgery with “Alphabet Soup”: PVE, ALPPS, TAE-PVE, LVD and RL	18
Cholangiocarcinoma: a review of the literature and future directions in therapy	17

An overview of the Chinese healthcare system	17
Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need	16
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights	16
The beneficial effects of intermittent fasting: an update on mechanism, and the role of circadian rhythm and gut microbiota	15
Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores	14
Minimally invasive liver resection for huge (≥10 cm) tumors: an international multicenter matched cohort study with regression discontinuity analyses	14
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice	13
Machine learning predicts unpredicted deaths with high accuracy following hepatopancreatic surgery	13
The gut-liver axis as a target of liver disease management	13
Appraisal of the current guidelines for management of cholangiocarcinoma—using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument	13
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	13
Liver venous deprivation: a bright future for liver metastases—but what about hepatocellular carcinoma?	12
The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study	11
Development and validation of a machine learning-based nomogram for prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis	11
Metabolic (dysfunction) associated fatty liver disease: more evidence and a bright future	11
Artificial intelligence is poised to revolutionize human liver allocation and decrease medical costs associated with liver transplantation	11
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: approaching clinical practice consensus?	11
Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex	11
How should liver hypertrophy be stimulated? A comparison of upfront associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) with rescue p	11
PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver	11
A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus	10
Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen	10
Combination immunotherapy with anti-VEGF/TKI for hepatocellular carcinoma: present and future perspective	10
Is there any correlation between liver graft regeneration and recipient’s pretransplant skeletal muscle mass?—a study in extended left lobe graft living-donor liver transplantation	10
Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study	10
Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity	10
Organ transplantation management in the midst of the COVID-19 outbreak: a synopsis	10
New-onset diabetes after adult liver transplantation in the Korean Organ Transplantation Registry (KOTRY) study	9
The internet hospital: how to combine with traditional healthcare model	9
Short- and long-term outcomes after hemihepatectomy for perihilar cholangiocarcinoma: does left or right side matter?	9
A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus	9
Liver resection versus intensity-modulated radiation therapy for treatment of hepatocellular carcinoma with hepatic vein tumor thrombus: a propensity score matching analysis	9
Surgery for pancreatic cancer: recent progress and future directions	8
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review	8
Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactions	8
Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma	8
Impact and clinical usefulness of genetic data in the surgical management of colorectal cancer liver metastasis: a narrative review	8
The socioeconomic aspects of nonalcoholic fatty liver disease: food insecurity as a novel risk factor for steatosis and liver fibrosis	8
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries	7
Hepatic artery reconstruction technique in liver transplantation: experience with 3,000 cases	7
Conversion surgery for hepatocellular carcinoma in the new era of targeted and immune checkpoint inhibitor therapies	7
A narrative review of the current and future role of robotic surgery in liver surgery and transplantation	7
Gallbladder volvulus	7
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma	7
Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a mul	7
Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?	7
Perihilar-cholangiocarcinoma: what really matters?	7
The uprising of metabolic dysfunction-associated fatty liver disease (MAFLD) in acute-on-chronic liver failure (ACLF)	7
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection	7
Robotic-assisted versus open total pancreatectomy: a propensity score-matched study	7

The upward trend in the immunotherapy utilization for hepatobiliary cancers	7
Optimizing future remnant liver prior to major hepatectomies: increasing volume while decreasing morbidity and mortality	7
SARS-CoV-2 and liver damage: a possible pathogenetic link	7
Mediterranean diet as the ideal model for preventing non-alcoholic fatty liver disease (NAFLD)	7
A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection	7
Intraoperative reperfusion assessment of human pancreas allografts using hyperspectral imaging (HSI)	6
Neutrophil extracellular traps contribute to the development of hepatocellular carcinoma in NASH by promoting Treg differentiation	6
Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma	6
Intra-operative trans-cystic indocyanine green (ICG) cholangiography: a high-sensitive method to identify bile leakage after hepatic resection	6
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	6
Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma	6
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice	6
Non-alcoholic steatohepatitis or metabolic-associated fatty liver: time to change	6
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	6
Automated liver tumor detection in abdominal ultrasonography with a modified faster region-based convolutional neural networks (Faster R-CNN) architecture	6
Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review	6
Non-alcoholic fatty liver disease (NAFLD) diagnosis and management—differentiating the essential from the ancillary and the present from the future	6
Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?	6
Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients	6
Proton beam therapy to bridge or downstage locally advanced hepatocellular carcinoma to living donor liver transplantation	5
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study	5
Comparative long-term outcomes for pancreatic volume change, nutritional status, and incidence of new-onset diabetes between pancreatogastrostomy and pancreatojejunostomy after pancreaticoduodenectomy	5
Safety analysis of COVID-19 vaccines in liver transplant recipients: a two-center study	5
Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents	5
Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice	5
Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic steatohepatitis: new insights from subcutaneous semaglutide	5
The beneficial impacts of splanchnic vasoactive agents on hepatic functional recovery in massive hepatectomy porcine model	5
Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation	5
No touch radiofrequency ablation for hepatocellular carcinoma: a conceptual approach rather than an iron law	5
Expert consensus on difficult airway assessment	5
Associating liver partition and portal vein ligation for staged hepatectomy versus sequential transarterial chemoembolization and portal vein embolization in staged hepatectomy for HBV-related hepatoc	5
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	5
Limited potential of resolvin D1 in treatment of cholestatic liver fibrosis	5
Use of imaging as staging and surgical planning for pancreatic surgery	5
Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease	5
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid	5
Revisiting human liver anatomy: dynamic watershed theory	5
Nonalcoholic fatty liver disease in type 2 diabetes: awareness is the first step toward change	4
New guidelines for the treatment of severe acute pancreatitis	4
Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma	4
Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis	4
The future of robotic liver surgery	4
Gut microbiota and hepatocellular carcinoma	4
Transcatheter arterial embolization-salvaged ALPPS, a novel ALPPS procedure especially for patients with hepatocellular carcinoma and severe fibrosis/cirrhosis	4
Radioembolization for neuroendocrine liver metastases is safe and effective prior to major hepatic resection	4
Editorial comment: a review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis	4
Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease	4
Addressing the variation in hepatic surgery for colorectal liver metastasis	4
Semaglutide for nonalcoholic steatohepatitis: closer to a solution?	4
Atezolizumab plus bevacizumab and tremelimumab plus durvalumab: how should we choose these two immunotherapy regimens for advanced hepatocellular carcinoma?	4
Uncommon indications for associating liver partition and portal vein ligation for staged hepatectomy: a systematic review	4
Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma	4
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	4
Clinical implications of the dual blockade of the PD-1/PD-L1 and vascular endothelial growth factor axes in the treatment of hepatocellular carcinoma	4
Not yet IDEAL?—evidence and learning curves of minimally invasive pancreaticoduodenectomy	4
Comparison of alternative arterial anastomosis site during liver transplantation when the recipient’s hepatic artery is unusable	4
Prospective study to evaluate the prognostic value of different nutritional assessment scores in liver surgery: NURIMAS Liver (DRKS00006340)	4
Understanding traditional Chinese medicine	4
Stool banking for fecal microbiota transplantation: ready for prime time?	4
A primary hepatic neuroendocrine tumor disguised as hepatocellular carcinoma	4
A simple scoring system to estimate perioperative mortality following liver resection for primary liver malignancy—the Hepatectomy Risk Score (HeRS)	3
A comparative study of pancreas transplantation between type 1 and 2 diabetes mellitus	3
The role of the robot-assisted procedure during total pancreatectomy: a viewpoint	3
Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection	3
Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality	3
Launching of the Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) in the Sultanate of Oman to manage HBP type of cancers	3
The challenge of hepatic vein reconstruction in surgical oncology	3
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021	3
The benefit of curative liver resection with a selective bile duct preserving approach for hepatocellular carcinoma with macroscopic bile duct tumor thrombus	3
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	3
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	3
Inflammation is king in liver resection for hepatocellular carcinoma	3
Laparoscopic surgery for colorectal liver metastases: moving forward while keeping feet on the ground	3
Vessels encapsulating tumor clusters in hepatocellular carcinoma: a unique and valuable pathological imaging	3
Genome-wide analysis of hepatitis B virus integration in hepatocellular carcinoma: Insights next generation sequencing	3
Screening for pancreatic cancer—a compelling challenge	3
Functional assessment of liver regeneration after major hepatectomy	3
Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma	3
Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre)	3
Roles of the human microbiome in cancer	3

Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China	3
Management of recurrent hepatocellular carcinoma after resection	3
Challenges in elucidating cholangiocarcinoma etiology	3
Robotic pancreaticoduodenectomy after the learning curve—a new hope	3
Improvement and development in anatomical hepatectomy for hepatocellular carcinoma	3
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up	3
Robotic versus laparoscopic liver resection for huge (≥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases	3
Combined non-alcoholic fatty liver disease and type 2 diabetes in severely obese patients—medium term effects of sleeve gastrectomy versus Roux-en-Y-gastric bypass on disease markers	3
Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis	3
Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma risk	3
Locally advanced pancreatic cancer: staging, operability, and the importance of multimodality therapy	3
Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre)	3
Current status of treatment for colorectal liver metastases in the United Kingdom	3
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections	3
The potential use of extended criteria donors and eligible recipients in liver transplantation for unresectable colorectal liver metastases in Central Sweden	3
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma	3
Emergency laparoscopic pancreatoduodenectomy as treatment for pancreatic head cancer-induced acute gastrointestinal hemorrhage, safe or not?	3
Synchronous colorectal liver metastases: therapeutic considerations	3
Liver transplantation for unresectable colorectal metastasis: a new hope	3
Role of C11-FDG dual-tracer PET-CT scan in metastatic screening of hepatocellular carcinoma—a cost-effectiveness analysis	3
Portal inflow reconstruction for liver transplantation with portal vein thrombosis	3
Liver cirrhosis and sarcopenia: a dreadful combination	2
Three-dimensional bioprinted liver tissue for transplantation: hope or hype?	2
An important measure taken for China Organ Transplant Response System	2
The role of associating liver partition and portal vein ligation for staged hepatectomy in the management of patients with colorectal liver metastasis	2
Have we really understood when the efforts of laparoscopic liver resection are justified?—a complexity-based appraisal of the differential benefit	2
Adjuvant chemotherapy for intrahepatic cholangiocarcinoma: far from a clinical consensus	2
A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma	2
Foregut bypass vs. restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals	2
French editorial from the ACHBPT: blood salvage and autotransfusion during liver transplantation for advanced hepatocellular carcinoma	2
Nutritional management after hepatopancreatobiliary surgery	2
Nonalcoholic fatty liver disease and type 2 diabetes: a burgeoning problem with unclear solutions	2
A female surgeon’s thoughts on gender attributes in surgery	2
Finding a role for cancer vaccines in pancreatic cancer: a model of resilience	2
Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma	2
Is robotic pancreatic surgery finally ready for prime-time?	2
Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis—implications for surveillance and future pharmacotherapy	2
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?	2
Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis	2
Advances in 3D bioprinting technology for liver regeneration	2
The future of adjuvant therapy in ampullary cancer: should we offer it to our patients?	2
Dietary health of medical workers: who’s taking care of it?	2
The future of minimally invasive liver resection for hepatocellular carcinoma BCLC stage 0–A	2
Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score: is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged h	2
Metabolic associated fatty liver disease (MAFLD): a milestone in the history of fatty liver disease	2
Validation of the Enhanced Recovery after Surgery (ERAS) society recommendations for liver surgery: a prospective, observational study	2
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts	2
The role of intraoperative electron radiotherapy in centrally located hepatocellular carcinomas treated with narrow-margin (<1 cm) hepatectomy: a prospective, phase 2 study	2
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice	2
Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery	2
Pediatric NAFLD: lessons from the gut	2
Refining selection criteria to further increase survival benefit in liver transplantation for unresectable colorectal liver metastases	2
Prognosis control surgery	2
Liver transplantation in the era of non-alcoholic fatty liver disease/metabolic (dysfunction) associated fatty liver disease: the dilemma of the steatotic liver graft on transplantation and recipient	2
Impact of nutritional status on outcome of pancreatic resections for pancreatic cancer and periampullary tumors	2
Conversion therapy of stage IVb unresectable gallbladder carcinoma	2
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma—a multicenter propensity score matching analysis	2
A haemorrhagic cholecystitis presenting as obstructive jaundice	2
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	2
Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection?	2
Does laparoscopic resection for colorectal cancer liver metastasis have a long-term oncologic advantage?	2
Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?	2
Tenofovir vs. entecavir in reducing hepatocellular carcinoma risk in patients with chronic HBV infection?—Still an unsolved question	2
Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases	2
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment	2
Clinical impact of omega-3 fatty acids (Ω3 FA) supplementation on liver surgery	2
How to balance the development of new surgical techniques and protection of patients’ health interests	2
Predicting post-operative pancreatic fistula: one size may not fit all	2
Can robotic liver resection compensate for weaknesses of the laparoscopic approach?	2
Comment on: Failure to rescue in patients with distal pancreatectomy: a nationwide analysis of 10,632 patients	2
Retrospective analysis of 45 cases of localized retroperitoneal Castleman disease from a single center	2
Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?	2
The rapidly expanding role of thermal ablation in the treatment of colorectal liver metastases	2
Liver segment 2+3 living donation in liver transplantation for colorectal liver metastases	2
Comment on: simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases	2
NAFLD or MAFLD: the data behind the debate	2
Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?	2
Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience	2
Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease	2
Tailoring bacterial taxa for immune cell modulation	2
Expert consensus on magnetic recanalization technique for biliary anastomotic strictures after liver transplantation	2
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	2